Miia Tiihonen

1.2k total citations
67 papers, 664 citations indexed

About

Miia Tiihonen is a scholar working on Geriatrics and Gerontology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Miia Tiihonen has authored 67 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Geriatrics and Gerontology, 15 papers in Physiology and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Miia Tiihonen's work include Pharmaceutical Practices and Patient Outcomes (12 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Nutrition and Health in Aging (10 papers). Miia Tiihonen is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (12 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Nutrition and Health in Aging (10 papers). Miia Tiihonen collaborates with scholars based in Finland, Sweden and Australia. Miia Tiihonen's co-authors include Sirpa Hartikainen, Irma Nykänen, Anna‐Maija Tolppanen, Riitta Ahonen, Heidi Taipale, Antti Tanskanen, Jari Tiihonen, Kaija Komulainen, Anna Maria Heikkinen and Anna Liisa Suominen and has published in prestigious journals such as Neurology, The American Journal of Gastroenterology and Epidemiology.

In The Last Decade

Miia Tiihonen

59 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miia Tiihonen Finland 15 171 136 111 108 86 67 664
Kazuyo Tsushita Japan 15 273 1.6× 67 0.5× 40 0.4× 278 2.6× 104 1.2× 61 979
Kaori Kitamura Japan 18 278 1.6× 74 0.5× 15 0.1× 23 0.2× 70 0.8× 63 1.0k
Adele L Towers United States 10 134 0.8× 142 1.0× 5 0.0× 21 0.2× 67 0.8× 15 831
Usama Feroze United States 17 309 1.8× 43 0.3× 7 0.1× 59 0.5× 76 0.9× 19 1.2k
Jose Ness United States 13 63 0.4× 114 0.8× 4 0.0× 114 1.1× 52 0.6× 17 917
Philip J. Garry United States 10 698 4.1× 298 2.2× 17 0.2× 58 0.5× 75 0.9× 14 1.0k
Yu Kaiho Japan 11 150 0.9× 45 0.3× 9 0.1× 9 0.1× 67 0.8× 27 497
Giulia Cairella Italy 12 190 1.1× 8 0.1× 68 0.6× 72 0.7× 86 1.0× 28 946
Christine S. Ritchie United States 10 435 2.5× 152 1.1× 12 0.1× 13 0.1× 67 0.8× 17 629
Kevin McCarroll Ireland 15 149 0.9× 44 0.3× 3 0.0× 34 0.3× 47 0.5× 50 703

Countries citing papers authored by Miia Tiihonen

Since Specialization
Citations

This map shows the geographic impact of Miia Tiihonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miia Tiihonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miia Tiihonen more than expected).

Fields of papers citing papers by Miia Tiihonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miia Tiihonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miia Tiihonen. The network helps show where Miia Tiihonen may publish in the future.

Co-authorship network of co-authors of Miia Tiihonen

This figure shows the co-authorship network connecting the top 25 collaborators of Miia Tiihonen. A scholar is included among the top collaborators of Miia Tiihonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miia Tiihonen. Miia Tiihonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tiihonen, Miia, et al.. (2025). Long‐Term Use of Benzodiazepines and Related Drugs in Persons With Major Depressive Disorder. Brain and Behavior. 15(11). e71085–e71085.
3.
4.
Haatainen, Kaisa, et al.. (2024). Improvement proposals and actions in medication error reports: Quality and strength: A cross‐sectional study. Health Science Reports. 7(9). e70077–e70077.
5.
Jyrkkä, Johanna, Sirpa Hartikainen, Jouni Ahonen, et al.. (2024). Prescribing Appropriate Medicines to Older Adults: A Finnish Experience with the Web-Based Meds75+ Database. Drugs & Aging. 41(8). 665–674.
6.
Tolppanen, Anna‐Maija, et al.. (2024). Statin use and the risk of Parkinson's disease in persons with diabetes: A nested case–control study. British Journal of Clinical Pharmacology. 90(6). 1463–1470.
7.
Komulainen, Kaija, et al.. (2024). Use of oral health care services among older home care clients in the context of an intervention study. Scandinavian Journal of Caring Sciences. 38(2). 426–437. 2 indexed citations
9.
Taipale, Heidi, Marjaana Koponen, Sirpa Hartikainen, et al.. (2023). The Cumulative Use of Muscle Relaxants and the Risk of Alzheimer’s Disease: A Nationwide Case-Control Study. Journal of Alzheimer s Disease. 91(4). 1283–1290. 1 indexed citations
11.
Koponen, Marjaana, et al.. (2022). Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease. Neurology. 98(12). e1273–e1281. 17 indexed citations
12.
Komulainen, Kaija, et al.. (2022). Eating problems among old home care clients. Clinical and Experimental Dental Research. 8(4). 959–968. 9 indexed citations
13.
Tolppanen, Anna‐Maija, et al.. (2022). Recent Hospitalization and Initiation of Antiepileptics Among Persons With Alzheimer’s Disease. Journal of the American Medical Directors Association. 24(2). 213–219.e6. 1 indexed citations
14.
Tolppanen, Anna‐Maija, et al.. (2022). Incidence of antipsychotic use among community dwellers with and without Parkinson's disease. Parkinsonism & Related Disorders. 103. 69–72. 4 indexed citations
15.
Tiihonen, Miia, et al.. (2022). Use of α1‐adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease. Pharmacoepidemiology and Drug Safety. 31(10). 1110–1120. 6 indexed citations
16.
Tolppanen, Anna‐Maija, Marjaana Koponen, Heidi Taipale, et al.. (2021). Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?. Journal of the American Medical Directors Association. 22(7). 1543–1547.e3. 6 indexed citations
17.
Taipale, Heidi, Anna‐Maija Tolppanen, Miia Tiihonen, et al.. (2017). No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer’s Disease. The American Journal of Gastroenterology. 112(12). 1802–1808. 67 indexed citations
18.
Tiihonen, Miia, et al.. (2017). Orthostatic Hypotension and Associated Factors Among Home Care Clients Aged 75 Years or Older - A Population-Based Study. The journal of nutrition health & aging. 22(1). 154–158. 7 indexed citations
19.
Taipale, Heidi, Anna‐Maija Tolppanen, Miia Tiihonen, et al.. (2017). No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
20.
Tiihonen, Miia, Heidi Taipale, Antti Tanskanen, Jari Tiihonen, & Sirpa Hartikainen. (2016). Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer’s Disease. Journal of Alzheimer s Disease. 52(1). 127–132. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026